Clinical outcome of patients with stage T1a prostate cancer

Journal of the Chinese Medical Association

Volumn 66, Issue 4, 2003, Pages 236-240

  Chen, Weng Ming ^a,b   Yang, Chi Rei ^a,b   Ou, Yen Chuan ^a,b   Cheng, Chen Li ^a,b   Kao, Yu Lin ^a,b   Ho, Hao Chung ^a,b   Su, Chung Kwang ^a,b   Chiu, Kun Yuan ^a,b   Chen, Jung Ta ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Gleason score; Prostate cancer; Serum PSA

Indexed keywords

GOSERELIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TRANSURETHRAL RESECTION; MORTALITY; PATHOLOGY; PROSTATE TUMOR;

AGED; DISEASE PROGRESSION; HUMANS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0141855013     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Chang CK, Yu HJ, Chan KWA, Lai MK. Secular trend and age-period-cohort analysis of prostate cancer mortality in Taiwan. J Urol 1997;158:1845-8.
2. O'Malley FP, Grignon DJ, Shum DT. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland. Virch Arch A Pathol Anat 1990;417:191-6.
3. Lowe BA, Listrom MB. Incidental carcinoma of the prostate. an analysis of the predictors of progression. J Urol 1988;140: 1340-4.
4. Epstein JI, Paull G, Eggleston JC, Walsh PC. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended follow-up. J Urol 1986;136:837-9.
5. Blute ML, Zincke H, Farrow GM. Long-term follow-up of young patients with stage A adenocarcinoma of the prostate. J Urol 1986;136:840-3.
6. Adolfsson J, Carstensen J. Natural course of clinically localized prostate adenocarcinoma in men less than 70 years old. J Urol 1991;146:96-8.
7. Aus G, Hugosson J, Norlen L. Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol 1995;154:460-5.
8. Kramer SA, Spahr J, Brendler CB, Glenn JF, Paulson DF. Experience with Gleason's histopathological grading in prostatic cancer. J Urol 1980;124:223-5.
9. Sogani PC, Israel A, Lieberman PH, Lesser ML, Whitmore WF. Gleason grading of prostate cancer: a predictor of survival. Urology 1985;25:223-7.
10. Catalona WJ. Grading and staging of prostate cancer. J Urol 1982;128:747-8.
11. Whitmore WF. The natural history of prostate cancer. Cancer 1973;32:1104-12.
12. Guinan P, Bhatti R, Ray P. An elevation of prostate specific antigen in prostatic cancer. J Urol 1987;137:686-9.
13. Oesterling JE, Chan DW, Epstein JI, Kimball AW, Bruzek DJ, Rock RC, et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 1988;139:766-72.